Browse by Author "Olivares Diez, José Manuel"

A COMPARATIVE COST-ANALYSIS OF INITIATING PREGABALIN OR SSRI/SNRI THERAPY IN BENZODIAZEPINE RESISTANT PATIENTS WITH GENERALIZED ANXIETY DISORDER

2012- Olivares Diez, José Manuel

A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain

2013- Olivares Diez, José Manuel

ADJUNCTIVE THERAPY WITH PREGABALIN IN GENERALIZED ANXIETY DISORDER PATIENTS WITH PARTIAL RESPONSE TO SSRI TREATMENT: A COST-CONSEQUENCES ANALYSIS IN MEDICAL PRACTICE IN SPAIN

2013- Olivares Diez, José Manuel

Analysis of serotonin transporter and 5-HT2A receptor clusters in peripheral lymphocytes as putative biomarkers of therapeutic efficacy in major depressive disorder

2014- Olivares Diez, José Manuel

Broadening diagnostic criteria of generalized anxiety disorders from DSM-IV: The impact on patient level of disability

2011- Olivares Diez, José Manuel

Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study

2012- Olivares Diez, José Manuel

Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia

2011- Olivares Diez, José Manuel; Pinal Fernández, Beatriz; Cinos Galan, Carmen Ines

Cost-consequences of adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to ssri treatment in clinical practice

2013- Olivares Diez, José Manuel

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

2013- Olivares Diez, José Manuel

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: Data from the US, Spain, Australia, and Belgium

2011- Olivares Diez, José Manuel

Improving treatment adherence in your patients with schizophrenia: The STAY initiative

2013- Olivares Diez, José Manuel

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

2015- Olivares Diez, José Manuel

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

2013- Olivares Diez, José Manuel

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain

2012- Olivares Diez, José Manuel

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia

2012- Olivares Diez, José Manuel

P01-173 - Effect of pregabalin on generalized anxiety disorder patients with severe symptoms of anxiety and depression refractory to duloxetin

2011- Olivares Diez, José Manuel

PATIENT FUNCTIONING IN GENERALIZED ANXIETY DISORDER SUBJECTS WITH PARTIAL RESPONSE TO PRIOR SSRI TREATMENT: THE EFFECT OF ADJUNCTIVE THERAPY WITH PREGABALIN IN DAILY MEDICAL PRACTICE

2013- Olivares Diez, José Manuel

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder

2019- Caruncho, Hector J.; Rivera Baltanas, Tania; Romay-Tallon, Raquel; Kalynchuk, Lisa E.; Olivares Diez, José Manuel [et al.]

Pellagra encephalopathy in the context of alcoholism: review and case report

2014- Olivares Diez, José Manuel; López García, Marta

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms

2015- Olivares Diez, José Manuel

RUNA digital repository

Browse by Author "Olivares Diez, José Manuel"

A COMPARATIVE COST-ANALYSIS OF INITIATING PREGABALIN OR SSRI/SNRI THERAPY IN BENZODIAZEPINE RESISTANT PATIENTS WITH GENERALIZED ANXIETY DISORDER ﻿

A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain ﻿

ADJUNCTIVE THERAPY WITH PREGABALIN IN GENERALIZED ANXIETY DISORDER PATIENTS WITH PARTIAL RESPONSE TO SSRI TREATMENT: A COST-CONSEQUENCES ANALYSIS IN MEDICAL PRACTICE IN SPAIN ﻿

Analysis of serotonin transporter and 5-HT2A receptor clusters in peripheral lymphocytes as putative biomarkers of therapeutic efficacy in major depressive disorder ﻿

Broadening diagnostic criteria of generalized anxiety disorders from DSM-IV: The impact on patient level of disability ﻿

Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study ﻿

Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia ﻿

Cost-consequences of adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to ssri treatment in clinical practice ﻿

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review ﻿

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: Data from the US, Spain, Australia, and Belgium ﻿

Improving treatment adherence in your patients with schizophrenia: The STAY initiative ﻿

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice ﻿

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain ﻿

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain ﻿

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia ﻿

P01-173 - Effect of pregabalin on generalized anxiety disorder patients with severe symptoms of anxiety and depression refractory to duloxetin ﻿

PATIENT FUNCTIONING IN GENERALIZED ANXIETY DISORDER SUBJECTS WITH PARTIAL RESPONSE TO PRIOR SSRI TREATMENT: THE EFFECT OF ADJUNCTIVE THERAPY WITH PREGABALIN IN DAILY MEDICAL PRACTICE ﻿

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder ﻿

Pellagra encephalopathy in the context of alcoholism: review and case report ﻿

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms ﻿

A COMPARATIVE COST-ANALYSIS OF INITIATING PREGABALIN OR SSRI/SNRI THERAPY IN BENZODIAZEPINE RESISTANT PATIENTS WITH GENERALIZED ANXIETY DISORDER

A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain

ADJUNCTIVE THERAPY WITH PREGABALIN IN GENERALIZED ANXIETY DISORDER PATIENTS WITH PARTIAL RESPONSE TO SSRI TREATMENT: A COST-CONSEQUENCES ANALYSIS IN MEDICAL PRACTICE IN SPAIN

Analysis of serotonin transporter and 5-HT2A receptor clusters in peripheral lymphocytes as putative biomarkers of therapeutic efficacy in major depressive disorder

Broadening diagnostic criteria of generalized anxiety disorders from DSM-IV: The impact on patient level of disability

Broadening of generalized anxiety disorders definition does not affect the response to psychiatric care: Findings from the observational ADAN study

Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia

Cost-consequences of adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to ssri treatment in clinical practice

Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: Data from the US, Spain, Australia, and Belgium

Improving treatment adherence in your patients with schizophrenia: The STAY initiative

Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice

Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia

P01-173 - Effect of pregabalin on generalized anxiety disorder patients with severe symptoms of anxiety and depression refractory to duloxetin

PATIENT FUNCTIONING IN GENERALIZED ANXIETY DISORDER SUBJECTS WITH PARTIAL RESPONSE TO PRIOR SSRI TREATMENT: THE EFFECT OF ADJUNCTIVE THERAPY WITH PREGABALIN IN DAILY MEDICAL PRACTICE

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder

Pellagra encephalopathy in the context of alcoholism: review and case report

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms